People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
In D’Iberville, those battling Parkinson’s Disease are slipping on the gloves and fighting back thanks to SAAD Healthcare’s Rock Steady Boxing classes.
Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease.
Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...
Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback